Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

Phase 1 Cancer Trials

Phase 1 cancer studies

Phase 1 cancer trials, on your terms

We are Phase 1 Cancer Trials. We help you learn about Phase 1 cancer trials, and if you are interested, we connect you with the study teams. The first step is a short conversation. It costs nothing and places you under no obligation.

Call (888) 927-9038
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed
Laboratory flasks holding blue and red liquids
Photo by Ivan S on Pexels
All locations

Phase 1 cancer studies in numbers

Phase 1 cancer studies recruiting in the U.S.
1,009
states with a study site
49
cities with a study site
393
studies that accept healthy volunteers
18

Source: ClinicalTrials.gov. Data processed .

Find Phase 1 cancer studies near you

These states have the most studies recruiting right now.

Phase 1 cancer studies recruiting now

As of November 17, 2026, 1,009 Phase 1 cancer studies are recruiting participants in the United States, according to ClinicalTrials.gov. This site lists only studies that are in Phase 1, including early Phase 1 and combined Phase 1/2, as each study is coded in the registry. This is what they have in common.

What they test

  • medications862
  • biologics such as vaccines or antibodies206
  • procedures131
  • radiation51
  • other approaches41

A study can test more than one.

Main purpose

  • treating a condition928
  • diagnosis44
  • basic science8
  • supportive care8

Phase

  • Early Phase 160
  • Phase 1540
  • Phase 1/2409

Who runs them

  • industry523
  • university, hospital or other444
  • government42

Who they enroll

  • adults (18 to 64)1,005
  • older adults (65 and over)962
  • children (under 18)83

18 also accept healthy volunteers.

Where: sites in 49 states. The cities with the most are Houston, TX (276), New York, NY (247), Boston, MA (178), Nashville, TN (173), Los Angeles, CA (156), Fairfax, VA (148), San Antonio, TX (118), Duarte, CA (109).

These counts come from each study's public record and change as studies open and close. Browse every location to see what is recruiting near you.

Source: ClinicalTrials.gov. Data processed . Each bar shows a count as a share of all 1,009 studies.

Recruiting now, by research area

Recently updated Phase 1 cancer studies

The 6 studies whose public records changed most recently, with some of the places each is recruiting. Select a study to read its full record on ClinicalTrials.gov.

  1. Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors

    • Phase 1
    • Ages 12 to 120
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Bethesda, MD · Fairway, KS
    Registry record
    NCT04222413 · updated
  2. Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Vivace Therapeutics, Inc
    Recruiting in
    Arlington, VA · Boston, MA · Chicago, IL · and 5 more U.S. locations
    Registry record
    NCT04665206 · updated
  3. The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

    • Phase 1/2
    • Up to age 22
    • All sexes
    Sponsor
    PedAL BCU, LLC
    Recruiting in
    Akron, OH · Albany, NY · Albuquerque, NM · and 129 more U.S. locations
    Registry record
    NCT04726241 · updated
  4. A Study to Evaluate the Safety and Tolerability of TOS-358 in Women With HR+ HER2- Breast Cancer

    • Phase 1
    • Ages 18 and older
    • Female participants
    Sponsor
    Totus Medicines
    Recruiting in
    Boston, MA · Calverton, MD · Chicago, IL · and 5 more U.S. locations
    Registry record
    NCT05683418 · updated
  5. A Study of Zedoresertib (Debio 0123) in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Zedoresertib (Debio 0123) in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Debiopharm International SA
    Recruiting in
    Chicago, IL · Dallas, TX · Houston, TX · and 4 more U.S. locations
    Registry record
    NCT05765812 · updated
  6. Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Institut de Recherches Internationales Servier
    Recruiting in
    Boston, MA · Cleveland, OH · Durham, NC · and 14 more U.S. locations
    Registry record
    NCT05786924 · updated

Source: ClinicalTrials.gov. Data processed .

Not sure which study fits?

Tell a coordinator what you are looking for. They will explain which Phase 1 cancer studies may be worth a closer look and what the next step is. Asking does not commit you to anything.

Call (888) 927-9038

How taking part works

The process has four steps. At each one, you choose whether to go on to the next.

  1. Tell us what you are looking for

    The first step is a phone call or a brief form. We ask only which cancer, or which kind of Phase 1 trial, you are looking into.

  2. Talk with a coordinator

    A coordinator talks you through the Phase 1 cancer trials that may be a match. Your questions are answered in plain language.

  3. Meet the study team

    Continuing is up to you. If you say yes, the people running the Phase 1 trial explain it to you point by point, and your eligibility is theirs to assess.

  4. Decide what is right for you

    Joining a study is voluntary, always. If you change your mind, you can leave at any time and for any reason.

Research areas

These are the areas of cancer research where we help you explore studies.

  • Breast Cancer studies

    Breast cancer research takes several forms. Some studies examine investigational medications, some combine therapies already in use, and others focus on screening or supportive-care approaches.

  • Lung Cancer studies

    In lung cancer, researchers study investigational medications, approaches to radiation, and screening methods. The work spans different types and stages of lung cancer.

  • Prostate Cancer studies

    Studies in prostate cancer assess investigational medications along with methods of imaging and monitoring. They cover the disease across its stages.

  • Melanoma studies

    Melanoma is a form of skin cancer. Studies in this area examine investigational immunotherapies, targeted medications, and combinations.

  • Lymphoma studies

    Lymphoma research covers both Hodgkin and non-Hodgkin lymphoma. Studies evaluate investigational medications and cell-based approaches.

  • Pancreatic Cancer studies

    In pancreatic cancer, studies look at investigational medications, therapies used in combination, and methods of early detection.

  • Not sure where you fit?

    A coordinator can point you in the right direction. All we need is a little information about what you are looking for.

Why people take part in Phase 1 cancer studies

Reasons for joining a Phase 1 cancer trial differ from person to person. Each one is a sound reason, and each merits a conversation with us or with the study team before you make up your mind.

  • Some people want a research team following their health closely while the study runs.
  • Some hope to learn more about the cancer they are living with.
  • Some want to help researchers answer questions whose results could inform how others are cared for later on.

Research and treatment are not the same thing. A Phase 1 trial is research, so a personal benefit from taking part is something no one is able to promise you. Our page on what a clinical trial is explains this in plain terms.

Your safety and your rights come first

Independent ethics committee review comes first for every Phase 1 study, and enrollment cannot open until that review is done. You are handed the written details before anyone asks for your agreement on any point. Our guides explain how informed consent works, how studies are reviewed and monitored, and which rights you keep from start to finish.

Common questions about Phase 1 cancer studies

Does it cost anything to ask about a study?

No. A conversation with Phase 1 Cancer Trials costs you nothing. Asking us questions does not enroll you in anything.

Do I have to take part if I call?

No. Each stage brings a fresh choice about going on, and that choice belongs to you. You are free to stop at any point.

Who decides whether I can join a study?

The study team does. They make that call once you have had a screening visit, and every Phase 1 trial sets requirements of its own. Our guide to eligibility and screening describes the process.

Ask about Phase 1 cancer studies

A coordinator will contact you once you share a few details. Asking about a Phase 1 cancer trial does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Learn more from independent sources

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 927-9038

or send a short form

How should we reach you?

Call